A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/69 (2006.01) A61K 38/05 (2006.01) A61K 38/55 (2006.01) A61P 1/00 (2006.01) A61P 9/10 (2006.01) A61P 29/00 (2006.01) A61P 31/00 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) A61P 37/08 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2339537
A method for regulating substrate activity in vivo is useful for the treatment of medical disorders such as inflammation, arteriolosclerosis and angiogenesis. The method involves the administration of an effective amount of a DPP-IV inhibitor to a patient in need of such treatment.
Ce procédé permet de réguler in vivo l'activité de substrat dans le cas du traitement de troubles médicaux tels que l'inflammation, l'artériosclérose et l'angiogenèse. Ce procédé consiste en l'administration au patient justifiant d'un tel traitement une quantité suffisante d'un inhibiteur du DDP-IV.
Wallner Barbara
Point Therapeutics Inc.
Smart & Biggar
LandOfFree
Regulation of substrate activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of substrate activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of substrate activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1747594